The sequence and structure of human testisspecific L-lactate dehydrogenase [LDHC4, LDHX; (L)-lactate: NAD' oxidoreductase, EC 1.1.1.27] has been derived from analysis of a complementary DNA (cDNA) clone comprising the complete protein coding region of the enzyme. From the deduced amino acid sequence, human LDHC4 is as different from rodent LDHC4 (73% homology) as it is from human LDHA4 (76% homology) and porcine LDHB4 (68% homology).
The testis-specific L-lactate dehydrogenase [LDH; (L)-lactate:NAD+ oxidoreductase, EC 1.1.1.27] isozyme of mammals (LDHX, LDHC4) constitutes one of the most dramatic examples of the temporal and spatial specificity of gene function (1) . In general, differential expression of two loci (Ldh-J and Ldh-2), encoding the LDHA and LDHB subunits, respectively, leads to the characteristic developmental and tissue-specific pattern of LDH isozymes in vertebrates (2) . Presumably, the LDH isozymes arose from a common ancestral form by gene duplication and divergence (2) . The presence of only LDHA4 in the lamprey is consistent with a single LDH gene in the earliest vertebrates or prevertebrates, while all other vertebrate species have the same paralogous set of isozymes, LDHA4 and -B4 (reviewed in ref. 3) . The LDHC gene (Ldh-3) that shows rigidly controlled tissue expression in fishes, the pigeon, and mammals may have arisen from at least two independent duplication events. It is likely that this third LDH gene is not homologous in fishes and mammals but rather that LDHC in advanced teleosts arose from a duplication of Ldh-2 (1, 3) .
Precise control of the LDHC gene locus occurs in the germinal epithelium of the mammalian testis. LDHC4 first appears in midpachytene primary spermatocytes and increases in concentration as spermatogenesis progresses to the spermatid (4) . There is recent evidence to suggest that transcription of the LDHC mRNA continues postmeiotically (5) . Furthermore, the rate of synthesis of LDHC4 is directly correlated with the amount of functional LDHC mRNA (6) .
Because of its close association with spermatogenesis, LDHC4 may be particularly suited to the specific metabolic needs of the germinal epithelium and spermatozoa (1, 7) . The three-dimensional structure and the molecular basis for certain unique functional properties have been reported for mouse LDHC4 (8) . Refinement of this structure (35) and immunochemical analysis (9) have provided data for constructing an antigenic map of the protein (10) . There is considerable interest in the possibility of using synthetic peptides mimicking LDHC4-specific epitopes for the development of a contraceptive vaccine (10) .
Antibodies to LDHC4 from mouse testes are not totally cross-reactive with this isozyme in human sperm extracts, suggesting only partial identity of antigenic determinants between these species (11). Our vaccine development studies have thus far used mouse LDHC4 epitopes as a model (12) . This isozyme can be routinely purified from mouse testes in large quantities (1) , whereas the scarcity of healthy human testes makes it impractical to obtain a sufficient amount of human LDHC4 for immunochemical dissection.
To determine the structure of antigenic determinants of human LDHC4, we have constructed and probed a human testes library and isolated and sequenced a complementary DNA (cDNA) clone comprising the complete protein coding region of LDHC4. Analysis of the deduced amino acid sequence shows that substantial differences in sequence occur between mouse and human in some but not all of the LDHC-subunit epitopes. § MATERIALS AND METHODS Construction of a Xgtll Human Testis cDNA Library. A human testis specimen was obtained after coadjuvant orchiectomy during operation of a prostatic cancer. RNA was extracted from the testis by the guanidinium isothiocyanate procedure (13) followed by CsCl centrifugation as described (14) , and total polyadenylylated RNA was selected by oligo(dT)-cellulose (15) . A cDNA expression library was constructed in Xgtll (16) 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. diluted 1:100 and absorbed with a lysate of E. coli strain Y1090. The testis Xgtll library was plated at a density of 2.5 x 104 plaque-forming units per 150-mm3 Petri dish with E. coli Y1090 as host bacteria. After growth at 420C and induction with isopropyl ,-D-thiogalactoside, the nitrocellulose filters were screened and bound antibody was detected by use of goat anti-rabbit IgG coupled to horseradish peroxidase (18) . The generation of murine monoclonal antibodies against mouse LDHC4 has been reported (11) . Monoclonal antibody F6H8 (an IgG2b, K chain) was used in a secondary screening and binding was detected with goat anti-mouse IgG labeled with horseradish peroxidase. Twelve putative clones were identified upon screening 1.8 x 105 pfu from the expression library. The positive clones were isolated as single plaques and rescreened as macroplaques (19) . Three of these 12 putative clones tested positive with the F6H8 monoclonal antibody to mouse LDHC4. These three clones contained inserts 0.8, 0.9, and 1.0 kilobase pairs (kbp) long that cross-hybridized with each other in Southern (20) blotting (Fig. 1) . In RNA blot analysis (21), the nick-translated 1.0-kb subfragment detected a single mRNA species of -1.5 kb in human testis RNA but not in placental RNA.
Sequence Analysis. cDNA inserts were subcloned into the EcoRI site of M13mpl9 and sequenced using the universal 17-mer sequencing primer (P-L Biochemicals); 17-and 18-mer oligonucleotides were synthesized on an Applied Biosystems (Foster City, CA) DNA synthesizer. Sequencing of the clones was accomplished by the Sanger dideoxy-chaintermination procedure (22) using the Klenow fragment of DNA polymerase and dATP[P5S] as tracer (23) . Homology searches were done using the Bionet system of Intelligenetics (Palo Alto, CA). Hydropathy analysis was carried out according to Kyte and Doolittle (24) . The sequence for the human LDHB4 subunit is unknown. Therefore, in sequence comparisons, porcine LDHB4 is substituted since a high degree of homology can be predicted based on the known LDHB4 sequences (88% between porcine-B4 and chicken-B4) (25) .
Antibody Assays. An ELISA (26) was used to test monoclonal antibody F6H8 binding to synthetic peptides containing epitopes of LDHC4. Microtiter wells of polyvinylchloride plates were coated with either a 100 ,uM solution of peptides or 0.1 uM mouse LDHC4. After appropriate washing and blocking steps (10), antibody was added to the well and binding was detected with peroxidase-labeled second antibody.
A RESULTS
The sequence of the human LDHC4 cDNA and the deduced amino acid sequence is presented in Fig. 2 The relatedness of known amino acid sequences of mammalian LDHA, -B, and -C subunits is compared in Table 1 .
Sequences were aligned to give greatest homology and relatedness determined by exact amino acid conservation over the length of the entire peptide, with any deletions counted as a difference. At the amino acid level the homology between mouse and human LDHC4 is 73%. At the nucleotide level, comparing our cDNA with a partial mouse cDNA clone (5) comprising bases 574-993, the sequences are 79% homologous. An antigenic map of mouse LDHC4 has been well defined by polyclonal (10, 12) , monoclonal (11) , and anti-peptide antibodies (9, 10) . Conservation of several epitopes between species permitted use of a rabbit anti-mouse LDHC4 antibody in identifying a cDNA clone encoding the human enzyme from the Xgtll expression library. Mouse LDHC4 contains nine surface accessible antigenic determinants (10, 11, 35) comprised of sequential epitopes. These are compared with human LDHC4 and the somatic isozymes in Fig. 3 .
Hydropathy analyses (24) of the mouse and human LDHC4 subunits indicate that the distribution of hydrophilic residues is similar for both enzymes and consistent with the position of the antigenic determinants described in Fig. 3 . The number of substitutions precludes predictions, for the most part, of antibody cross-reactivity between these isozymes. However, one epitope can be firmly assigned on the basis of binding by monoclonal antibody F6H8. This antibody made against mouse LDHC4 identified a cDNA clone encoding the human enzyme from the Xgtll expression library. Comparison of epitopes (Fig. 3) reveals that a substantial part of the sequence encompassed by residues 211-226 is highly conserved between mouse and human LDHC but likely to be antigenic because of differences from LDHA and -B. Monoclonal antibody F6H8 specifically bound to peptide mouse LDHC 211-226, but not to 211-220 (Table 2 ), confirming our prediction that the 10 conserved residues of this peptide represent the sequential epitope. The highly variable amino-terminal arm of the mouse LDH subunit contains an epitope encompassing residues 5-16 (9) . Six of the 12 amino acids comprising this sequence differ between mouse and human LDHC4 (Fig. 3) . In addition to human LDHC 5-16 having a greater net negative charge, it probably differs in conformation from mouse LDHC 5-16 because of the proline -* glutamic acid change at position 13 (Fig. 3) . In spite of these differences in amino acid sequences, antisera to mouse LDHC 5-16 bound to human spermatozoa (27) , although not to the expression vector fusion protein (data not shown). Anti-mouse LDHC 5-16 binding to sperm is consistent with our observations that fertility was reduced in female baboons immunized with this peptide sequence (28) .
With the possible exception of the epitopes defined by residues 211-226, 304-316, and 5-16, the remaining sequential determinants of human LDHC4 defined by the mouse model are much more conserved with respect to the somatic isozymes, especially LDHA (Fig. 3) . The homologies ofthese epitopes with the human sequence are summarized in Table  3 . Antibodies to some of these sequences could cross-react with human somatic tissues and therefore be unsuitable for immunocontraception.
DISCUSSION
A cDNA coding for human LDHC4 has been identified on the basis of message source, antibody recognition, sequence comparisons, and functional domains. Although we cannot compare the human LDHC4 sequence with that of human LDHB4, it is unlikely that we have cloned the LDHB gene by mistake. The polyclonal antiserum used to screen the Xgtll library does not cross-react with the somatic isozymes (1, 29) . The monoclonal antibody recognized an epitope (12) specific to both mouse and human LDHC4. The cDNA when used as a probe hybridizes only to a 1.5-kb mRNA from testes but not from placenta, and the LDHC4 mRNA is known to be 15-to 20-fold more abundant than that for the somatic isozymes in the testes (6) .
We did not expect that the deduced amino acid sequence of the human LDHC4 subunit would differ as much as 27% from the sequence of the rodent LDHC4 polypeptides ( Table  1 ). The homology among LDHC4 isozymes from testes of several mammalian species has been established by immunochemical analysis (29) . In general, homologous somatic isozymes differ between species by 12% or less. The comparison of the rodent and human LDHC4 amino acid sequences suggests that the genes encoding the mammalian LDHC subunits have diverged from each other to a greater extent than either the Ldh-J or Ldh-2 genes from their homologous counterparts.
Amino acid sequence analysis of mouse LDHC4 led Li et al. (30) to conclude that LDHA and LDHB are more related to each other than either is to LDHC. These investigators (30) propose that the duplication giving rise to the LDHC gene is older than 750 million years, possibly originating in an invertebrate. Whitt (31) notes that if all the Ldh genes are evolving at the same rate, LDHC4 must have been encoded in an ancient Ldh gene, perhaps even older than the 500-600 million year origin of the LDHA and -B genes. He suggests (31), alternatively, a more rapid rate of Ldh-3 evolution from a more recent origin. However, there is no need to abandon the original concept of LDH gene evolution (2) . The gene encoding the LDHC subunit in fishes very likely represents a duplication of the LDHB gene locus in view of the immunochemical similarities of these subunits. LDHC in mammals, however, may represent a duplication of the LDHA gene. Human LDHC is more closely related in amino acid sequence conservation to human LDHA (76%) and porcine LDHA (75%) than to porcine LDHB (68%). This latter conclusion is supported by the epitope homologies in Table 3 as well as by the chromosomal localization of the human LDHC gene syntenic with the LDHA gene on chromosome 11 (32) .
Development of a human contraceptive vaccine relies on the observation that antibodies to LDHC4 do not cross-react with lactate dehydrogenases of somatic tissues (29, 33, 34) . Antibodies to LDHC4, however, do cross-react with the LDHC4 subunits of different species and these reagents have been useful in mapping antigenic determinants. The relatively low degree of homology between mouse and human LDHC4 makes necessary a reevaluation of the sequential and conformational epitopes of the human protein. Antibodies specific for human LDHC4 should have increased specificity and efficacy over anti-mouse antibodies in abrogating human sperm function. However, predictions of antigenicity and antibody specificity from sequence differences of mouse LDHC4 with the somatic isozymes cannot be extrapolated to the human LDHC sequence. These putative epitopes of human LDHC4 may be recognized as self because of similarity to the somatic LDHA sequence (Fig. 3) . For example, the sequence of the coenzyme binding loop, residues 97-110, differs in only 2 of 14 amino acids between human LDHC and LDHA, compared to 6 of 14 differences between the mouse and human isozymes (Table 3) . Similarly, conserved sequences might not provoke an immune reaction, or they may cause an autoimmune response. In either case, these determinants would not be suitable candidates to develop a synthetic contraceptive vaccine.
Expression of the LDHC cDNA in an appropriate vector will permit in-depth study of the biochemical and antigenic properties of human LDHC4. Furthermore, the human cDNA clone identified in this study provides a useful probe with which to investigate the evolutionary relationships ofthe three LDH genes. In addition, we will be able to use this probe as a tool to study the exquisite temporal control and tissue specificity that are characteristic of LDHC gene expression, particularly as seen in the mammalian testes. The identification of regulatory sequences of the Ldh-3 gene will aid in elucidating the mechanisms of developmental expression of human LDHC4.
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